Matching-adjusted indirect treatment comparison of [177Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [177Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours
2018 ◽
Vol 79
(3)
◽
pp. AB187
Keyword(s):
2019 ◽
Vol 139
◽
pp. 143-148
◽
2019 ◽
Vol 143
(1)
◽
pp. 190-200.e20
◽
Keyword(s):